在喘中呼吸道炎症的研究进展:一本图书法分析分析
Lang Liye1, Zhao Hui, Huang Fuchun
1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Medicine
|July 19, 2024
概括
这份图书统计分析回顾了20年的喘气道炎症研究,确定了关键出版物和趋势. 它突出了研究热点,如炎症细胞和分子,用于未来的研究.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 图书统计学 图书统计学
背景情况:
- 全球喘患病率上升,影响了3.58亿人.
- 呼吸道炎症是喘的一个关键特征,引发了大量的研究兴趣.
- 由于经济和健康原因,了解喘的炎症机制至关重要.
研究的目的:
- 系统地审查和可视化有关喘呼吸道炎症的文献.
- 确定20年来研究趋势,主要贡献者和出版模式.
- 为未来关于喘呼吸道炎症的研究提供参考.
主要方法:
- 从2003年到2022年,对1892篇文章进行了图书统计分析.
- 从科学网络核心集合数据库中获取的文献.
- 数据使用可视化软件CiteSpace和VOSviewer进行分析.
主要成果:
- 出版物显示,2003-2022年间的增长波动.
- 中国,美国和韩国在出版物方面处于领先地位.
- 过敏和临床免疫学杂志是最多产的期刊.
结论:
- 在过去二十年中,关于喘气道炎症的研究显著扩大.
- 关键的研究热点包括炎症细胞组件,通路分子和生物制剂.
- 建议对这些领域进行进一步的研究,以推进喘治疗.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267
Drugs Used in Lower Respiratory Disorders: Overview
390
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
390


